Watchlist Price Alert

Arrowhead Pharmaceuticals... (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

15.65

-0.31 (-1.94%)

At close: Jun 25, 2025, 2:21 PM

Arrowhead Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Cash & Equivalents	102.69M	110.89M	108M	184.43M	143.58M	221.8M	30.13M	24.84M	85.37M
Short-Term Investments	578.28M	292.74M	268.39M	183.35M	171.91M	36.9M	46.4M	40.77M	n/a
Long-Term Investments	n/a	n/a	105.87M	245.59M	137.49M	44.18M	n/a	n/a	n/a
Other Long-Term Assets	4.48M	210K	29.12M	272K	265.36K	144.15K	141.92K	141.92K	122.33K
Receivables	n/a	n/a	1.41M	10.26M	845.67K	661.36K	327.38K	67.8K	75K
Inventory	n/a	n/a	-21.61M	4.36M	4.25M	3.32M	1.27M	867.36K	1.29M
Other Current Assets	4.97M	7.08M	20.2M	2.19M	1.78M	2.56M	640.12K	1.36M	3.77M
Total Current Assets	695.47M	419.52M	376.4M	384.6M	322.37M	265.25M	78.77M	67.9M	90.5M
Property-Plant & Equipment	431.29M	335.56M	168.59M	66.02M	47.02M	23.21M	13.94M	15.51M	15.39M
Goodwill & Intangibles	8.56M	10.26M	11.96M	13.66M	15.36M	17.06M	18.76M	20.46M	22.16M
Total Long-Term Assets	444.33M	346.03M	315.54M	325.55M	200.13M	84.6M	32.84M	36.12M	37.67M
Total Assets	1.14B	765.55M	691.94M	710.15M	522.5M	349.85M	111.61M	104.02M	128.18M
Account Payables	11.39M	35.87M	2.87M	9.46M	6.83M	7.65M	2.81M	4.08M	12.23M
Deferred Revenue	n/a	866K	74.1M	111.06M	19.29M	77.77M	600.00	5.27M	2.57M
Short-Term Debt	6.34M	-866K	2.78M	2.25M	n/a	n/a	223.82K	208.51K	194.31K
Other Current Liabilities	432K	435K	88.16M	23.5M	19.31M	6.7M	5.4M	11.02M	9.25M
Total Current Liabilities	103.17M	105.46M	74.1M	146.54M	40.68M	97.07M	12.36M	18.7M	25.64M
Long-Term Debt	393.18M	268.33M	n/a	n/a	20.04B	n/a	2.1M	2.33M	2.53M
Other Long-Term Liabilities	341.36M	n/a	n/a	n/a	-20.04B	3.7M	1.9M	2.13M	2.47M
Total Long-Term Liabilities	845.57M	372.93M	511.88M	154.79M	20.04M	8.74M	4M	4.45M	7.51M
Total Liabilities	948.74M	478.39M	585.98M	301.33M	60.72M	105.81M	16.37M	23.16M	33.15M
Total Debt	510.55M	115.17M	81.58M	25.55M	21.14M	n/a	2.33M	2.53M	2.73M
Common Stock	217K	200K	105.96M	197K	194.75K	187.88K	180.88K	167.16K	162.12K
Retained Earnings	-1.63B	-1.03B	-820.75M	-644.69M	-503.84M	-419.29M	-487.27M	-432.82M	-398.44M
Comprehensive Income	4.75M	-3.22M	-136K	-69K	18.43K	-391.62K	-21.56K	33.23K	7.45K
Shareholders Equity	185.44M	271.34M	105.96M	408.82M	461.78M	244.59M	95.8M	81.42M	95.58M
Total Investments	578.28M	292.74M	374.26M	428.95M	309.4M	81.08M	46.4M	40.77M	n/a